Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for USA stock GSK Glaxosmithkline Plc. Dated: 28 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 49.17 and Closed at: 49.70, which is 0.93% of previous session's close. It moved within a range of 48.98 and 49.80
The session was a Bullish session with an average volume of 3586700, which is 33.35% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
A Golden cross was found 3 days back on short term averages
Support for tomorrow is 49.34 and resistance for tomorrow is 50.16
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 49.19, 48.67 resistance for tomorrow's hourly charts is 50.01, 50.31
10 Day SMA for Glaxosmithkline Plc (GSK) is 50.17 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 49.86 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 50.86 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 51.15 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 52.49 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 49.86 and 200 DMA is at 52.49, while 50 DMA and 100 DMA are at 50.86 and 51.15 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 49.86 and 20 EMA is at 50.1
| Date | Closing Price | 20 SMA | 20 EMA |
| 28 Mon Sep | 49.70 | 49.86 | 50.1 |
| 25 Fri Sep | 49.24 | 49.92 | 50.14 |
| 24 Thu Sep | 49.65 | 49.97 | 50.23 |
| 23 Wed Sep | 49.71 | 50.06 | 50.29 |
| 22 Tue Sep | 50.72 | 50.18 | 50.35 |
| 21 Mon Sep | 51.08 | 50.23 | 50.31 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 50.86 and 50 EMA is at 50.67
| Date | Closing Price | 50 SMA | 50 EMA |
| 28 Mon Sep | 49.70 | 50.86 | 50.67 |
| 25 Fri Sep | 49.24 | 50.87 | 50.71 |
| 24 Thu Sep | 49.65 | 50.92 | 50.77 |
| 23 Wed Sep | 49.71 | 50.98 | 50.82 |
| 22 Tue Sep | 50.72 | 51.01 | 50.87 |
| 21 Mon Sep | 51.08 | 51.02 | 50.88 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 51.15 and 100 EMA is at 51.21
| Date | Closing Price | 100 SMA | 100 EMA |
| 28 Mon Sep | 49.70 | 51.15 | 51.21 |
| 25 Fri Sep | 49.24 | 51.16 | 51.24 |
| 24 Thu Sep | 49.65 | 51.17 | 51.28 |
| 23 Wed Sep | 49.71 | 51.18 | 51.31 |
| 22 Tue Sep | 50.72 | 51.19 | 51.34 |
| 21 Mon Sep | 51.08 | 51.2 | 51.35 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 52.49 and 200 EMA is at 50.4
| Date | Closing Price | 200 SMA | 200 EMA |
| 28 Mon Sep | 49.70 | 52.49 | 50.4 |
| 25 Fri Sep | 49.24 | 52.49 | 50.41 |
| 24 Thu Sep | 49.65 | 52.49 | 50.42 |
| 23 Wed Sep | 49.71 | 52.47 | 50.43 |
| 22 Tue Sep | 50.72 | 52.47 | 50.44 |
| 21 Mon Sep | 51.08 | 52.46 | 50.44 |
Glaxosmithkline Plc has performed better than Brookdale Senior in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Abbvie Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Abbvie Inc, about 4.94% more returns!
Glaxosmithkline Plc has performed better than Xenetic Biosciences in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Utah Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Utah Medical, about 5.81% more returns!
Glaxosmithkline Plc has performed better than Sonoma Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Radnet Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Nature S in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Kura Oncology in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Helius Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Helius Medical, about 29.6% more returns!
Fulgent Genetics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Fulgent Genetics, about 16.53% more returns!
Ensign Group has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Ensign Group, about 3.47% more returns!
Corcept Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 3.1% more returns!
Glaxosmithkline Plc has performed better than Axsome Therapeutics in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 3.64% more returns!
Glaxosmithkline Plc has performed better than Argenx Se in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Akebia Therapeutics in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Ac Immune in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Acadia Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Glaxosmithkline Plc in short term but the buy signal is initial and weak.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Glaxosmithkline Plc in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.2 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
